News
September 14, 2023
Amgen, MSD and Gilead feature in IPHA’s campaign that demonstrates the promise of science through animation style storytelling. Thursday, 14th September 2023 The Irish Pharmaceutical Healthcare […]
July 3, 2023
Last Friday, June 30th, IPHA published the Transfer of value (ToV) Disclosure data for 2022. The total ToV amount for 2022 was €26,140,927 which is a […]
April 28, 2023
In 2022, it took on average 567 days from EMA authorisation to availability to patients of new innovative medicines in Ireland, among the slowest in western […]
March 2, 2023
Annual Conference to assess innovation pipeline and supportive policies Proposals from the European Commission to weaken intellectual property rights will degrade the development and delivery of […]
February 24, 2023
The decision by Minister for Health, Stephen Donnelly T.D. to publish the Mazars Report today has been welcomed by the Irish Pharmaceutical Healthcare Association as a […]
December 5, 2022
61% would follow doctor’s advice on vaccination 51% have received two or more booster Covid-19 vaccine doses 77% believe children should study science at school Almost […]
November 7, 2022
IPHA urges Government to heed slide in Europe’s research and development investments and clinical trials activity as policymakers in Brussels weigh legislative changes Europe could lose […]
November 4, 2022
The biopharmaceutical industry is surging. But believing that the surge is permanent, or inevitable, would be a mistake. Like other industries, we are buffeted by international […]
October 20, 2022
Comparator research, conducted by the Swedish Institute for Health Economics, finds: Cancer survival has improved since the 1990s but demographic pressures could push diagnoses to 42,000 […]